Search Results for "Depression After Ischemic Stroke"
Original Source: Depression in acute stroke: prevalence, dominant symptoms and associated factors. A systematic literature review.
Purpose. The aim of this review was to provide a comprehensive analysis of the state of knowledge about post-stroke depression (PSD) in the acute phase, focusing on: (a) the prevalence of depressive disorder and depressive symptoms, (b) the dominant depressive symptoms, (c) the factors associated with PSD and (d) the follow-up consequences. Method. A computer-aided search in MEDLINE, CINAHL, PsychInfo, EMBASE, British Nursing index, Pub Med and Ovid Nursing Database was performed. We systematically searched...
Matching Channels
Matching News
IST-3 Supports Wider Use of tPA in Ischemic Stroke Patients
Results from IST-3 show that IV tPA can be given safely in a wide variety of situations of acute ischemic stroke and benefits patients regardless of blood pressure, glucose, or stroke subtype. Medsc...
Adding clopidogrel to aspirin therapy reduces risk of second stroke
Adding a second drug to aspirin therapy reduced the risk of a second stroke in the weeks after Chinese patients had a minor ischemic (due to a clot) stroke or a transient ischemic attack (TIA), accord...
Ischemic stroke on the rise among N.J. children
Stroke is one of the top 10 causes of death among children according to the National Stroke Association. A new study published today shows that in New Jersey, the diagnosis of ischemic stroke in child...
Vorapaxar Fails Secondary Stroke Prevention Test (CME/CE)
(MedPage Today) -- The investigational antiplatelet vorapaxar given with standard antiplatelet therapy to ischemic stroke patients increased brain bleeds and recurrent ischemic stroke without any drop...
New Ischemic Stroke Guidelines: The Nuts and Bolts
Dr. Mark Alberts dissects the new AHA/ASA guidelines for the early management of acute ischemic stroke. Medscape Neurology
ZZ Biotech and Laureate collaborate on ischemic stroke drug
Laureate Biopharma Services and ZZ Biotech teamed up on process development and manufacturing of ischemic stroke treatment 3K -More-
Silent infarcts prognostic in young stroke patients
Silent ischemic lesions are common and are associated with a high rate of recurrent events in young patients with acute ischemic stroke, report researchers.
Neuropeptide Biomarker Differentiates Ischemic Stroke
A biomarker of blood-brain barrier disruption may distinguish an ischemic stroke from a transient ischemic attack or an...
Matching PubMed Articles
Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke.
OBJECTIVE: This study was to test whether serum BDNF or tissue plasminogen activator (tPA) is correlated with the development of depression at the acute stage of stroke. METHODS: Hundred ischemic stro...
Blood Biomarkers of Ischemic Stroke.
This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysio...
New insights in antiplatelet therapy for patients with ischemic stroke.
Acute treatment and long-term secondary prevention of noncardioembolic ischemic stroke and transient ischemic attack (TIA) include initiation of antiplatelet therapy. Antiplatelet agents currently use...
An association between migraine and ischemic stroke has been observed for many years but exact mechanisms by which migraine can lead to stroke are currently still under investigation. Migraine is rela...
Endogenous granulocyte colony-stimulating factor: A biomarker in acute ischemic stroke.
Granulocyte colony-stimulating factor (G-CSF) may protect ischemic brain injury either in animal or human. No studies have reported that endogenous G-CSF (enG-CSF) level is related to the severity of...
